Tinzaparin Completed Phase 4 Trials for Renal Failure, Chronic Renal Failure Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01930396Use of Tinzaparin for Anticoagulation in Hemodialysis